Form D · Pharmaceuticals
Bayhill Therapeutics, Inc.
San Mateo, CA · CIK 0001290157
Offering snapshot reported Jul 17, 2009 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2009 | Initial | $9,999,999 | No comparison | 1 | SEC filing |
| Jan 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 24, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-65425
Source: Form D, filed Jul 17, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frederick J. Dotzler | Director |
| Hideki Garren | Executive |
| Robert S. King | Executive |
| Rosina Maar Pavia, M.D. | Director |
| Richard P. Powers | Director |
| Joanne Quan, M.D. | Executive |
| Mark W. Schwartz | Director, Executive |
| Lawrence Steinman, M.D. | Director |
| David E. Thompson | Director |
| Paul B. Westberg | Executive |
| James N. Woody, M.D., Ph.D. | Director |
| Philip M. Young | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1810 Gateway Drive, Suite 150
San Mateo, CA, 94404
San Mateo, CA, 94404